Halloween fun can turn risky—educate patients and prepare teams to prevent candy, costume, and safety hazards. HEPA purifiers in US elementary school classrooms reduced respiratory virus diversity but not overall viral burden. Mucoactive agents failed to significantly reduce pulmonary exacerbations in non–cystic fibrosis bronchiectasis. A new ACCP guideline offers recommendations for selecting biologic agents for adults with severe asthma. Adding sotatercept to background therapy lowered the risk for clinical worsening in early PAH. A systematic review in Geriatric Nursing suggests that anxiety impacts 1 in 3 older patients with COPD. Inhaled molgramostim significantly improved lung gas exchange and QOL among patients with autoimmune PAP. A single dose of clesrovimab protected healthy infants against mild, moderate, and severe RSV disease. Emphysema on baseline LDCT for lung cancer screening predicted all-cause, COPD, and CVD mortality within 25 years. Minute alterations in the mechanical environment of lung tissue may initiate a process that leads to lung fibrosis. Thoracic surgeon Maria Lucia Madariaga, MD, shared considerations for clinicians preparing to operate on patients with NSCLC. Pairing TPVB with ESPB significantly reduces rebound pain after video-assisted thoracoscopic surgery. Patients under 80 and those 80 and older who underwent robotic surgery for lung cancer had similar outcomes. An EHR-embedded COPD care pathway shortened hospital LOS, lowered costs, and improved adherence to evidence-based practices. A molecular allergy chip reliably detected allergic asthma, revealing that 73% of the asthma cohort had allergic asthma. For older adults, the RSVpreF vaccine reduced hospitalizations for RSV-related respiratory tract disease. POCUS using devices that attach to smartphones reduced hospital stays and costs for patients with undifferentiated dyspnea. Asthma symptom severity and immune response gender disparities are tied to sex-specific gene expression in immune cells. One-third of patients with small-cell lung cancer showed symptoms of cancer-related CI prior to starting chemotherapy. Kawsar R. Talaat, MD, discusses research showing higher risks for mortality, AKI, and severe RF with RSV hospitalization.